A spotlight on diabetes care and research at Sinai Health
With one in three people in Canada affected by diabetes, it’s likely that you or someone in your life is impacted, underscoring the urgent need for advancements in the field.
As a pioneering institution in diabetes care, research, and education, the Leadership Sinai Centre for Diabetes (LSCD) at Mount Sinai Hospital, part of Sinai Health provides specialized care to 20,000 patients annually, serving as Canada’s top referral center for complex diabetes cases, with a focus on diabetes, endocrinology, and gestational diabetes.
Our leadership in:
Three types of diabetes
Three types of diabetes treated at Sinai Health – type 1, type 2 and gestational.
LSCD researchers are at the forefront of research in technology-driven diabetes care for their work such as understanding the risk factors for diabetic ketoacidosis in type 1 diabetes, developing education tools to prevent it, and investigating transformative drugs, including transporter inhibitors (SGLT inhibitors) for type 2 diabetes, to enhance blood sugar control.
This program annually supports 775 women and their newborns, dedicated to improving gestational diabetes management using and testing technologies like automated insulin delivery systems.